Product image of Oversano (Ketorolac Trometamol) supplied by GNH India

Oversano

Active Ingredient:
Ketorolac Trometamol
Origin:
EU

Oversano (Ketorolac Trometamol)

Ketorolac Trometamol, the active ingredient in Oversano, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as a tablet for oral use. It is employed for short‑term management of moderate to severe pain, typically after surgical procedures, in adult patients. GNH India supplies Oversano as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH India supplies Oversano as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Manufacturer / TM Owner

Nassington Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ketorolac Trometamol is an NSAID that provides analgesic and anti‑inflammatory effects for several acute pain conditions.

  • Post‑operative pain: helps achieve effective pain relief after surgery.
  • Renal colic: reduces pain associated with kidney stones.
  • Musculoskeletal injury: alleviates pain from sprains, strains and contusions.
  • Acute migraine (off‑label): may lessen headache intensity when other treatments fail.
  • Dental pain: provides short‑term relief following dental procedures.

How It Works

  • Ketorolac trometamol inhibits cyclo‑oxygenase (COX‑1 and COX‑2) enzymes, decreasing the synthesis of prostaglandins that mediate inflammation, pain and fever. By reducing prostaglandin levels, it diminishes peripheral sensitisation and central pain signalling, producing potent analgesic effects comparable to opioid analgesics in the short term.

Side Effects

Ketorolac Trometamol may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.
  • Headache: mild to moderate intensity.
  • Dizziness or vertigo.
  • Elevated blood pressure.
  • Renal function changes: transient increase in serum creatinine.
  • Injection site irritation (if administered parenterally).

Serious or Rare Side Effects

  • Gastrointestinal bleeding or ulceration.
  • Severe hypersensitivity reactions including anaphylaxis.
  • Thrombotic events such as myocardial infarction or stroke.
  • Acute kidney injury.
  • Severe skin reactions such as Stevens‑Johnson syndrome.
  • Hepatotoxicity.

Precautions & Warnings

Ketorolac Trometamol should be used with caution and under professional supervision.

  • Assess renal function: avoid use in patients with severe renal impairment.
  • Monitor gastrointestinal risk: use gastro‑protective agents in high‑risk individuals.
  • Evaluate cardiovascular status: avoid in patients with recent myocardial infarction.
  • Limit duration: restrict use to the shortest possible period, generally not exceeding five days.
  • Review concomitant NSAID or anticoagulant therapy: increase bleeding risk.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and light.

Avoid Interactions

Ketorolac Trometamol can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): heightened risk of serious bleeding.
  • Other NSAIDs or aspirin: additive gastrointestinal toxicity.
  • Selective serotonin reuptake inhibitors (SSRIs): increased bleeding tendency.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors, ARBs: may reduce renal perfusion and function.
  • Diuretics: potential for reduced kidney function.
  • Lithium: NSAIDs can raise lithium serum levels.
  • Methotrexate: decreased renal clearance may increase toxicity.
  • Corticactives (e.g., prednisone): heightened risk of ulceration.

Frequently Asked Questions

Oversano contains ketorolac trometamol, an NSAID indicated for short‑term management of moderate to severe pain, such as post‑operative pain, renal colic, and acute musculoskeletal injuries. It is intended for adult patients and is typically prescribed for brief treatment periods.

Ketorolac trometamol blocks the cyclo‑oxygenase enzymes COX‑1 and COX‑2, which reduces the production of prostaglandins—compounds that trigger inflammation, pain and fever. Lower prostaglandin levels diminish peripheral and central pain signalling, providing strong analgesic effects.

The specific dose and duration of Oversano are determined by the prescribing clinician based on the patient’s condition, pain severity, and overall health status. Healthcare professionals follow local prescribing guidelines and adjust the regimen as needed.

Ketorolac trometamol is generally contraindicated in the third trimester of pregnancy because of the risk of fetal complications. Use during earlier stages or while breastfeeding should only occur if the prescriber judges that the benefit outweighs potential risks.

To request Oversano, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Oversano (ketorolac) provides analgesia comparable to weak opioids and is often more potent than ibuprofen or naproxen for short‑term use. However, it carries a higher risk of gastrointestinal and renal adverse effects, so it is typically limited to five days or less and used when stronger pain relief is needed.

Store Oversano tablets at ambient temperature, below 25 °C, in the original container to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Oversano is supplied as oral tablets that are taken with water, usually with food or a full glass of liquid to reduce stomach irritation. The exact administration schedule is set by the prescriber.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, cardiovascular events like heart attack or stroke, and acute kidney injury. Patients should be monitored closely for these events, especially if they have pre‑existing risk factors.

Oversano should be avoided in patients with known hypersensitivity to ketorolac or other NSAIDs, those with active peptic ulcer disease, severe renal impairment, recent coronary artery bypass grafting, or in the third trimester of pregnancy. A healthcare professional should evaluate suitability before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.